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Operative stroke complicating carotid endarterectomy is traditionally treated by reex- 
ploration of the operative site to correct a potentially causative l sion; however, attempts 
are not made to diagnose or treat the intracranial arterial occlusion. A 65-year-old man 
had a right hemiplegia during a left carotid endarterectomy that was caused by premature 
reversal of heparin, which resulted in thrombosis of his left anterior cerebral artery. On 
reexploration, the patient was treated with a 1-hour infusion of I million U urokinase 
through an indwelling carotid shunt. A repeat arteriogram demonstrated patency of the 
left anterior cerebral artery, with complete clot dissolution and resolution of the right 
hemiplegia on awakening. Natural history studies of stroke and prospective, angiographi- 
cally controlled clinical trials of intraarterial thrombolytic therapy for acute stroke 
support he use of intraoperative intraarterial infusion of urokinase as part of a therapeu- 
tic approach to patients who have an ischemic stroke during carotid endarterectomy. 
(J Vase Surg 1996;24:1008-16.) 
Carotid endarterectomy is the most commonly 
performed vascular operation in the United States. 
Although neurologic complications arc infrequent, 
their occurrence can be devastating to both patient 
and surgeon. Operative strokes complicating carotid 
endarterectomy are reluctantly accepted by surgeons, 
with treatment directed at reexploration of the oper- 
ative site to repair a potentially causative lesion in the 
operative field, most commonly without any attempt 
to define or correct intracranial ischemia. 
In recent years, substantial interest in the use of 
thrombolytic therapy for acute stroke has yielded data 
to support he hypothesis that dissolution of symp- 
tom-causing thrombi in the cerebral arteries may lead 
to the resolution of the stroke symptoms.1 
This paper summarizes a patient who had a stroke 
during carotid endarterectomy as a result of  prema- 
ture heparin reversal. The patient awoke with a dense 
right hemiplegia c used by acute thrombosis of the 
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left anterior cerebral artery (ACA). The patient was 
successfully treated with a high-dose regional infu- 
sion of uroldnase (UK), which restored patency to 
the ACA and resolved the right hemiplegia. 
CASE REPORT 
A 65-year-old Hispanic man sought medical attention 
with a history of two previous right-hemispheric strokes 
followed by near full recovery. The patient was referred for 
evaluation because of recent left-hemispheric transient 
ischemic attacks and left-eye amaurosis fugax. The patient's 
physical evaluation was unremarkable except for a harsh left 
cervical bruit. Caroti d artery duplex imaging demonstrated 
a 40% to 50% stenosis of the right internal carotid artery 
(ICA) with a small ulcer, and a 70% stenosis of the left ICA 
associated with marked ulceration. Because of the multi- 
plicity of the patient's symptoms, the previous troke, and 
the duplex evidence of contralateral ulceration, a head 
computed tomographic (CT) scan and a preoperative ca- 
rotid arteriogram were obtained. A 40% stenosis with a 
small ulcer of the right ICA was confirmed, as well as the 
ulcerated stenosis of the left ICA (Fig. 1). Furthermore, 
both ACAs were patent; however, there was no cross-filling 
of either ACA as a result of occlusion of the anterior 
communicating artery (Fig. 2). 
A routine left carotid endarterectomy was performed 
with the patient under general anesthesia with continuous 
20-lead electroencephalographic monitoring. The patient 
was given 7500 U heparin before carotid artery clamping, 
and the endarterectomy was performed in the standard 
fashion without a shunt because the electroencephalogram 
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Fig. 1. Carotid arteriogram demonstrates cervical portion of left carotid bifurcation and shows 
ICA stenosis with multilobulated ulceration. 
(EEG) remained normal after carotid artery clamping. Be- 
cause the ICA was approximately 6 mm in diameter, the 
arteriotomy was closed primarily. Unfortunately, prota- 
mine was infused in a full heparin-reversal dose approxi- 
mately 15 minutes before the carotid artery clamps were 
removed. 
When the patient awoke from anesthesia on the oper- 
ating room table, a dense right hemiplegia was present. The 
patient was reanesthetized, and the incision was reopened. 
Interestingly , during reexploration when the carotid artery 
was clamped, the EEG demonstrated significant slowing. A 
Pruitt-Inahara carotid artery shunt (Ideas for Medicine, 
Inc., Clearwater, Fla.) was inserted that has a sideport for 
access to the flow sn-eam. The EEG reverted to baseline 
after the shunt was placed. The endarterectomized segment 
was smooth without adherent fibrin or thrombus, and there 
was no inrimal flap. An on-table arteriogram was obtained 
through the side arm of the shunt, which demonsrxated 
occlusion of the previously patent left ACA (Fig. 3), which 
corresponded to the regional slowing of the EEG. One 
million U UK dissolved in 100 ml of nine-tenths-normal 
saline solution was slowly infused through the side port 
during the next hour. A repeat arteriogram (Fig; 4) dem- 
onstrated contrast refilling the left ACA. Because the qual- 
ity of the intraoperative films was suboptimal and because 
persistent intracerebral thrombus was suspected, a formal 
carotid and intracranial rteriogram was requested, antici- 
paring that a cerebral microcatheter would be inserted 
directly into the left ACA if residual thrombus was found. 
The shunt was removed, and the arteriotomy and neck 
wounds were closed. Remaining intubated and under gen- 
eral anesthesia, the patient was taken to the neuroradiology 
suite. Through a right femoral artery approach, the left 
cervical carotid artery was examined under fluoroscopy and 
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Fig. 2. A, Intracranial view of carotid arteriogram demonstrates patent right middle cerebral 
artery and right ACA; anterior communicating artery is occluded (arrow). B, Intracranial 
arteriogram demonstrates patent left middle cerebral artery and left ACA and again indicates 
occluded anterior communicating artery (arrow). C, Lateral intracranial rteriogram from left 
carotid injection demonstrates patent left ACA (arrow). 
was found to be normal. Intracranial images demonstrated 
uninterrupted flow of contrast into the left ACA (Fig. 5). 
The previously thrombosed ACA was now patent, and all 
visible thrombus had resolved. An immediate CT scan 
demonstrated no change from the preoperative scan and 
failed to demonstrate any evidence of hemorrhage. The 
patient was then transferred to the ICU. When the patient 
awakened, it was immediately evident hat the right hemi- 
plegia had resolved. 
During the ensuing 2 days, the patient's response to 
simple commands was inappropriate and he demonstrated 
weakness of his left arm. A repeat head CT scan on the third 
day after surgery demonstrated bilateral nonhemorrhagic 
infarcts in the region supplied by the posterior cerebral 
arteries (Fig. 6). In the meantime, the patients pulmonary 
status deteriorated and right lowerqobe pneumonia devel- 
oped, which subsequently cleared with treatment. After 
resolution of the patient's medical problems, he was trans- 
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Fig. 3. Initial operative arteriogram through left ICA shunt demonstrates occlusion of left 
ACA (arrow). 
ferred to the rehabilitation u it, where he continued to 
have good strength and function of the right side of his 
body and his expressive aphasia nd overall neurologic 
condition improved 
DISCUSSION 
Carotid endarterectomy has been proved to be 
effective in reducing stroke and subsequent neuro- 
logic events in patients who have focal hemispheric 
and retinal ischemia, 2 3 and in asymptomatic patients 
who have significant cervical carotid artery disease. 4,s 
The most dreaded complication of carotid endarter- 
ectomy is precisely that which the operation is de- 
signed to avoid: an ischemic erebral infarction. Cur- 
rent efforts ha the care of patients who have strokes 
during carotid endarterectomy focus on preventing 
additional events, but do nothing to diagnose or 
correct the existing intracranial ischemia. This case 
offers a new approach to those patients who have a 
neurologic deficit din'rag carotid enterectomy. In this 
particular instance, occlusion f  the left ACA likely 
resulted from in sltu thrombosis after the premature 
reversal of  heparin while the carotid artery clamps 
were in place Because the anterior communicating 
artery was occluded, the left ACA represented an 
"end artery," susceptible to thrombosis if inflow was 
occluded unprotected by anticoagulation. 
When the neurologic deficit was documented, an 
approach was tal<en that was designed to correct any 
celMcal lesion and eliminate the intracerebral rterial 
occlusion that caused the right hemiplegia. In recent 
years, thrombolytic therapy for acute stroke has re- 
ceived widespread interest. Clinical observations 
from previous and ongomg studies offer support for 
the approach taken in our patient. 
In patients who had carotid-territory strokes, del 
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Fig. 4. Repeat operative arteriogram through ICA shunt 1 hour later after infusion of l  million 
U UK. There appears to be reperfusion of left ACA (arrow). 
Zoppo and colleagues 6 reported either partial or 
complete recanalization i  90% of patients (18 of 20) 
who had thrombotic stroke and who were treated 
with extended local intraarterial or regional infusion 
of UK plasminogen activator or streptokinase within 
1 to 4 hours of symptom onset. Fifty-five percent of 
patients demonstrated complete or partial clinical 
recovery; however, no patient recovered in the ab- 
sence ofrecanalization. This is a consistent finding in 
experimental models of stroke 7,s and other prospec- 
tive angiographically controlled trials ofthrombolytic 
therapy for acute stroke. TM Hemorrhagic infarction 
was seen in 20% of patients, was independent of 
recanalization, and subsequently resolved in all pa- 
tients. Similar observations were reported by Mori 
and colleagues 9 when they used regional delivery of 
UK plasminogen activator. These studies typify the 
observations of other prospective angiographically 
controlled studies of intraarterial delivery of throm- 
bolytic agents for carotid-territory stroke. 
Hemorrhagic transformation of ischemic brain 
tissue includes both hemorrhagic nfarction and pa- 
renchymal hematoma. The prognosis is vastly differ- 
ent between these two entities. Hemorrhagic infarc- 
tion refers to petechial or confluent petechial 
hemorrhage in the region ofischemic injury and may 
represent only a temporary CT or magnetic reso- 
nance imaging finding without clinical consequences. 
Parenchymal hematoma refers to a defined mass of 
blood in brain tissue that may cause a mass effect or 
extend into the ventricle. Large natural history stud- 
ies of carotid-territory stroke have documented that 
hemorrhagic infarction occurs in 43% to 46% and 
parenchymal hematoma in 11% to 14%.12,~s 
Although patient numbers are small, the intensity 
of the arteriographic investigation i recent prospec- 
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Fig. 5. Intracranial view of formal postoperative left carotid arteriogram demonstrates p tent 
left ACA (arrow), without evidence of hemorrhage. 
Table I. Rate of recanalization i arteriographically controlled trials of intraarterial thrombolytic 
therapy for carotid-territory stroke 
Durat ion Arteriogra~hic 
Author Agent n A T (hr) recana!ization 
del Zoppo et al. 6 SK/u -PA 20 7.6 1 to 4 90% 
Mori et ill? u-PA 22 4.5 0.2 to 0.5 46% 
Matsumoto and Satoh 1° u-PA 40 1-24 0.2 to 0.5 60% 
Theron et al.11 SK/u-  PA 12 2-504 < 1.0 100% 
AT, time from ischemic event to initiation of treatment in hours; Duration, duration of lyric infusion in hours; SK, streptoldnase; u.PA, 
urokinase plasminogen activator. 
tire studies offers insight regarding the outcome of 
treatment. Short-duration delivery of an intraarterial 
thrombolytic agent early in the course of the cerebral 
ischemic event is associated with a 46% to I00% 
chance ofrecanalization (Table I). In all angiographi- 
cally controllcd studies of ischemic stroke, patient 
recovery has been directly linked to recanalization 
(repcrfusion) of the occluded artery mad is most likely 
to occur if treataTnent is instituted soon after the 
ischemic event. Hemorrhagic transformation in- 
creases ignificantly as the time from onset of isch- 
emia to initiation of treatment incrcases (particularly 
if treatment is initiated more than 6 hours from 
symptom onset; Table II). Interestingly, there is no 
relationship between intracercbral hemorrhage and 
recanalization. 
Because operative neurologic deficits can be diag- 
nosed early after the neurologic event occurs, treat- 
ment with the regional infusion f the thrombolytic 
agent o resolve the intracerebral occlusion is appro- 
priate. When treated within the first 4 hours, there is 
no apparent increased risk ofintracranial hemorrhage 
when compared with nontreated control subjects. 
The potential for restoring perfusion to the ischemic 
area, and therefore rcsolution of the neurologic def- 
icit, is significantly higher in patients who receive 
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Fig. 6. CT scan 3 days after surgery demonstrates muttifocal infarcts; however, there is no 
evidence of infarction in distribution of ACA, and there is no evidence of intracranial hemor- 
rhage. 
Table  I I .  Intracranial bleeding complications ofintraarterial thrombolytic therapy for 
carotid-territory stroke in arteriographically controlled trials 
Hemorrhage 
Author Agent n A T H I  PH 
del Zoppo et  a l .  6 SK/u-PA 20 7.6 20% 0% 
Moil et al. 9 u-PA 22 4,5 4.5% 13.6% 
Theron et at. 11 SK/u-PA 12 <10.0 0% 25% 
AT, time from ischemic event to initiation of treatment in hours; H/, hemorrhagic infarction; PH, parenchymal hematoma; SI C 
streptokinase; u-PA, urokinase plasminogen activator. 
thrombolysis than in untreated patients. We would 
be unwilling to offer this treatment for occlusions 
present longer than 6 hours: 
Arteriographic imaging of  the intracranial vascu- 
lature is important. A l though the quality o f  operative 
arteriograms of  the cerebral vasculature is frequently 
suboptimal, having all available information on these 
patients is important. The presence of  a vascular 
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occlusion, its relationship to the patient's clinical 
presentation, and the documentation f  the outcome 
are important for gathering future data. Because neu- 
rologic complications after endarterectomy occur in- 
frequently in any single center, an individual vascular 
surgeon is unlikely to develop an experience broad 
enough to answer the many important questions that 
arise when treating these patients. For example, 
should lytic therapy be withheld ifintracranial rterial 
occlusion is not documented? Is regional infusion 
into the ICA safer or more effective than local (in- 
n'athrombus } infusion? Is there a difference between 
fibrinolytic agents? Clues to the answers to these 
questions may be available if a registry is established 
and the aggregate experience of  the multiple centers 
is analyzed. 
Successful use of the intraoperative infusion of 
UK for embolic stroke during carotid endarterec- 
tomy has been reported by Barr et al. ]4 They diag- 
nosed a right middle cerebral artery embolic occlu- 
sion when the somatosensory evoked potential (right 
cortical SEP Ps0 wave} did not recover with carotid 
artery shunting, and an on-table intracranial carotid 
arteriogram demonstrated occlusive thrombus in the 
proximal middle cerebral artery. The thrombus was 
successfully sed, with 500,000 U UK delivered into 
the thrombus through a microcatheter that was ap- 
propriately positioned under fluoroscopic guidance 
Barr et al. demonstrated the benefit of catheter- 
directed lysis, and their observations suggest that 
intracranial arterial occlusion should be suspected if
intraoperative abnormalities of SEP or EEG occur 
that do not normalize after the insertion of a properly 
functioning carotid artery shunt. 
The patient reported herein demonstrated reper- 
fusion of  a thrombosed ACA with resolution of a 
dense hemiplegia fter intraoperative high-dose re- 
gional infusion of UK. The cause of the patient's 
other infarcts is uncertain, although they are most 
consistent with multifocal small-vessel thrombosis 
that occurs in a similar fashion to the ACA thrombo- 
sis. 
Ifreexploration ofthe operated carotid artery in a 
patient who had an operative neurologic deficit dem- 
onstrated thrombosis of the ICA, we would recom- 
mend gentle balloon catheter thrombectomy, opera- 
tive angioscopy to examine for adherent thrombus. 
an intracranial arteriogram, and intraarterial UK in- 
fusion through the side port of  the carotid artery 
shunt. Advancing a minicatheter into an occluded 
intracranial artery (if present) would lil<ely increase 
the chance of successful lysis. 
Intraarterial delivery of UK is commonly used to 
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Fig. 7. Suggested approach to patients who have ischemic 
strokes during carotid endarterectomy. 
treat acute arterial and graft occlusion. Mthough it 
has not been approved by the Food and Drug Ad- 
ministration for this specific indication, it has become 
a valuable adjunctive therapy for eliminating throm. 
bus in various parts of the arterial tree. Because the 
halfqife of UK is approximately 14 minutes, the 
systemic thrombolytic effect should dissipate after 2-3 
half-lives. Used judiciously, this form of treatment 
should not mcur any additional medical-legal risk 
over any other available drug used for a nonapproved 
indication. 
The currently available data from trials ofthrom- 
bolytic therapy for acute stroke and this case, which 
documents arteriographic repelffusion of an occluded 
artmw with resolution of a dense hemip!egia fter 
intraoperative UK for an operative stroke, support 
continued investigation of this therapeutic approach 
for patients who have intraoperative n urologic defi- 
cits during carotid endarterectomy (Fig. 7). 
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